ClinicalTrials.gov vs Covid-19 India
Same instrument, two spec sheets — measured, not claimed.
ClinicalTrials.gov vs Covid-19 India: common questions
Which is more reliable, ClinicalTrials.gov or Covid-19 India?
On our scheduled checks, Covid-19 India leads on measured uptime — ClinicalTrials.gov at 99.02% versus Covid-19 India at 100% over 90 days. These are our own probe results, not provider claims; the uptime bars above show the day-by-day record for both.
Which is faster, ClinicalTrials.gov or Covid-19 India?
ClinicalTrials.gov has the lower median latency in our checks — ClinicalTrials.gov responds in 243 ms versus Covid-19 India at 311 ms (P50). Tail latency (P95) is in the table above; for most workloads the median is the number that shapes how the API feels.
Do ClinicalTrials.gov and Covid-19 India need an API key?
Neither needs a paid key — ClinicalTrials.gov is callable with no signup, and Covid-19 India is callable with no signup. Both are quick to prototype with; rate limits still apply.
Can I call ClinicalTrials.gov and Covid-19 India from the browser?
Only ClinicalTrials.gov is browser-friendly — it returns CORS headers over HTTPS. Covid-19 India needs a server-side call or proxy, so factor that into which one fits a front-end project.
Are ClinicalTrials.gov and Covid-19 India free for commercial use?
ClinicalTrials.gov has unclear commercial terms, and Covid-19 India has unclear commercial terms. We track service terms and the data license as separate fields — see the Commercial use and Data license rows above, and confirm both before shipping either in a paid product.